参考文献/References:
[1].尹言,尹春琳. 围产期心肌病长期预后相关因素研究进展[J]. 中国循环杂志,2022,37(9):964-968.
[2].Sliwa K,Mebazaa A,Hilfiker-Kleiner D,et al. Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy(PPCM):EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM[J]. Eur J Heart Fail,2017,19(9):1131-1141.
[3].中国医师协会心力衰竭专业委员会,国家心血管病专家委员会心力衰竭专业委员会,中华心力衰竭和心肌病杂志编委会,等. 围生期心肌病诊断和治疗中国专家共识2021[J]. 中华心力衰竭和心肌病杂志,2021,5(1):3-16.
[4].Sarma AA,Hsu S,Januzzi JL,et al. First trimester cardiac biomarkers among women with peripartum cardiomyopathy:are there early clues to this late-pregnancy phenomenon[J]. Am J P erinatol,2023,40(2):137-140.
[5].Katende A,Roos L,Urio VZ,et al. Recovery of left ventricular systolic function in peripartum cardiomyopathy:an observational study from rural Tanzania[J]. BMC Cardiovasc Disord,2024,24(1):123-129.
[6].李婕,楼颖素,张晓青. 妊娠期合并心脏病孕妇血清脑钠肽和肌钙蛋白I预测母婴妊娠结局的临床价值分析[J]. 中国妇幼保健,2022,15(1):37-41.
[7].Dockree S,Brook J,Shine B,et al. Pregnancy-specific reference intervals for BNP and NT-pro BNP-changes in natriuretic peptides related to pregnancy[J]. Endocr Soc,2021,5(7):bvab091.
[8].Imran TF,Mohebali D,Lopez D,et al. NT-proBNP and predictors of event free survival and left ventricular systolic function recovery in peripartum cardiomyopathy[J]. Int J Cardiol,2022,357:48-54.
[9].Ricke HM,Hoes MF,Pfeffer TJ,et al. In peripartum cardiomyopathy plasminogen activator inhibitor-1 is a potential new biomarker with controversial roles[J]. Cardiovasc Res,2019,116(11):1875-1886.
[10].Hu CL,Li YB,Zou YG,et al. Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy[J]. Heart,2007,93(4):488-490.
[11].Peng BS,Frederick B,Hidalgo MD,et al. Peripartum cardiomyopathy:a cause of heart failure in young women[J]. Med Forum,2017,18(3):15.
[12].覃凤椰,关海霞,王晓黎. 催乳素在传统靶腺之外的作用和意义[J]. 国际内分泌代谢杂志,2022,42(6):497-500.
[13].Forster O,Hilfiker-Kleiner D,Ansari AA,et al. Reversal of IFN-γ,oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy[J]. Eur J Heart Fail,2008,10(9):861-868.
[14].Bauersachs J,Arrigo M,Hilfiker-Kleiner D,et al. Current management of patients with severe acute peripartum cardiomyopathy,practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy[J]. Eur J Heart Fail,2016,18(9):1096-1105.
[15].Rufo E,Martinez-Couselo S,Jimenez-Anon L,et al. Marked geographical variation in the prevalence of macroprolactinemia[J]. Clin Chem Lab Med,2022,60(3):71-74.
[16].Hilfiker-Kleiner D,Kaminski K,Podewski E,et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy[J]. Cell,2007,128(3):589-600.
[17].Sliwa K,Blauwet L,Tibazarwa K,et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy:a proof-of-concept pilot study[J]. Circulation ,2010,121(13):1465-1473.
[18].郭丽,雷娟,李玲. 可溶性fms样酪氨酸激酶1与胎盘生长因子比值与重度子痫前期孕产妇分娩后血压及降压药需求的相关性研究[J]. 实用心脑肺血管病杂志,2020,28(10):48-55.
[19].Espeche W,Minetto J,Salazar MR. Utility of 24-hour ambulatory monitoring and the Sflt-1/PlGF ratio in preeclampsia prediction[J]. Hypertens Res,2024,47(5):1436-1437.
[20].Patten IS,Rana S,Shahul S,et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy[J]. Nature,2012,485(7398):333-338.
[21].Mebazaa A,Seronde MF,Gayat E,et al. Imbalanced angiogenesis in peripartum cardiomyopathy diagnostic value of placenta growth factor [J]. Circ J,2017,81(11):1654-1661.
[22].屈建新,邢冬梅,刘新灿. 半乳糖凝集素-3在心肌纤维化相关心血管疾病中的研究进展[J]. 心血管病学进展,2019,40(4):605-608.
[23].Ka SM,Chou YL,Chen A. Galectin-3 involved in the development of IgA nephropathy[J]. J Am Soc Nephrol,2023,34(11S):244-245.
[24].Yu L,Ruifrok WP,Meissner M,et al. Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis[J]. Circ Heart Fail,2013,6(1):107-117.
[25].Yang ZH,Hao JW,Liu JP,et al. Electroacupuncture alleviates ciliary muscle cell apoptosis in lens-induced myopic guinea pigs through inhibiting the mitochondrial signaling pathway[J]. Int J Ophthalmol,2023,16(12):1942-1951.
[26].Sliwa K,Skudicky D,Bergmann A. Peripartum cardiomyopathy,analysis of clinical outcome,left ventricular function,plasma levels of cytokines and Fas/APO-1[J]. J Am Coll Cardiol,2000,35(3):701-705.
[27].Sliwa K,F?rster O,Libhaber E,et al. Peripartum cardiomyopathy,inflammatory markers as predictors of outcome in 100 prospectively studied patients[J]. Eur Heart J,2006,27(4):441-446.
[28].Song J,Steidle L,Steymans I,et al. The mitochondrial Hsp70 controls the assembly of the F1FO-ATP synthase[J]. Nat Commun,2023,14(1):39.
[29].Chakafana G,Spracklen TF,Kamuli S,et al. Heat shock proteins potential modulators and candidate biomarkers of peripartum cardiomyopathy[J]. Front Cardiovasc Med,2021,8:633013.
[30].Woodley DT,Fan J,Cheng CF,et al. Expression of Concern:participation of the lipoprotein receptor LRP1 in hypoxia-HSP90α autocrine signaling to promote keratinocyte migration[J]. J Cell Sci,2023,136(21):jcs261643.